K-Stat-ET Tablet
Images are for reference. Actual packaging may vary.
Strip of 10 tablets • TabletPrescription requiredSchedule H
K-Stat-ET Tablet
Tranexamic Acid (500mg) + Ethamsylate (250mg)
₹271.80
Strip of 10 tablets • Tablet
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Ethamsylate 250 mg
+1 more active ingredient
How It Works
Tranexamic Acid inhibits plasminogen activation, preventing fibrinolysis and stabilizing blood clots.
Medicine Strength
250 mg
All Active Ingredients
Ethamsylate250 mg
Tranexamic Acid500 mg
Uses & Benefits
Medical applications
K-Stat-ET Tablet is a combination pharmaceutical formulation containing Tranexamic Acid 500 mg and Ethamsylate 250 mg, indicated for the management and prevention of excessive bleeding. Tranexamic Acid is an antifibrinolytic agent that inhibits the activation of plasminogen to plasmin, thereby stabilizing formed clots and reducing fibrinolysis. Ethamsylate acts by improving capillary endothelial stability and promoting platelet adhesion, which enhances primary hemostasis.
Read full descriptionShow less
The synergistic effect of these two agents makes K-Stat-ET effective in controlling hemorrhagic conditions such as menorrhagia, postoperative bleeding, dental extractions, and bleeding associated with various surgical procedures. It is also utilized in managing bleeding disorders where clot stabilization is essential. The tablet should be administered under medical supervision, with dosage tailored according to the severity of bleeding and patient response.
Contraindications include active intravascular clotting, hypersensitivity to components, and caution is advised in patients with thromboembolic disorders or renal impairment. Adverse effects may include gastrointestinal disturbances, hypersensitivity reactions, and rare thrombotic events. K-Stat-ET Tablet offers a reliable therapeutic option for clinicians aiming to achieve effective hemostasis in diverse clinical scenarios.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side effects
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Safety Advice
Alcohol
Information regarding the use of K-Stat-ET Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of K-Stat-ET Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
K-Stat-ET Tablet should be used with caution in patients with kidney disease. Dose adjustment of K-Stat-ET Tablet may be needed. Please consult your doctor.
Exercise Caution
Breastfeeding
It is not known whether K-Stat-ET Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
K-Stat-ET Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of K-Stat-ET Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for K-Stat-ET Tablet
